Heartflow, Inc.
HTFL · XNASCIK 1464521fmd_0JRRKW8CXQE09CEY7DGZ45YN48Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2023 to Sep 30, 2026, 12 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total revenues | 87 | 126 | 176 |
| Cost of revenue | 29 | 31 | 41 |
| Gross profit | 58 | 94 | 135 |
| Research and development | 36 | 44 | 65 |
| Selling, general and administrative | 95 | 112 | 134 |
| Total operating expenses | 131 | 156 | 199 |
| Operating income | (73) | (61) | (64) |
| Interest expense | 25 | 23 | 15 |
| Interest and investment income | 5 | 4 | 6 |
| Other non-operating income (expense) | (22) | (35) | (53) |
| Income before taxes | (95) | (96) | (117) |
| Income tax expense | 1 | 0 | (0) |
| Net income from continuing operations | (96) | (96) | (117) |
| Net income | (96) | (96) | (117) |
| Net income to common shareholders | (124) | (96) | (117) |